INO-1001

PARP inhibitor · Inotek Pharmaceuticals Corporation

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for INO-1001, covering 2006-11-29 to 2015-03-25. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of INO-1001 in Patients Undergoing Heart Surgery That Involves Heart-lung Bypass [Phase 2]